Bright Peak Therapeutics

Bright Peak Therapeutics is a biotech company in Del Mar, United States, founded in 2017. It has raised $232.0M across 3 rounds, most recently a $90.0M Series C in June 2024.

Next-generation multifunctional precision immunotherapies

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$232.0M
Last Round
$90.0M Series CJun 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Bright Peak Therapeutics is a biotechnology company advancing next-generation multifunctional precision immunotherapies. The company uses world-class protein engineering capabilities to create multi-functional PD-1 inhibitors, integrating both novel and validated mechanisms. Co-founded in 2017 by Vijaya Pattabiraman and Jeffrey Bode, Bright Peak is backed by leading healthcare investors including Versant Ventures, Fidelity Management & Research Company, RA Capital Management, Qatar Investment Authority, Invus, Alexandria Venture Investments, Venrock, and KB Investment. The company is co-located in Basel, Switzerland and San Diego (Del Mar), California, with a dual focus on cancer and autoimmune diseases.

Summary

It lists 51–200 employees. It has raised $232.0M in total across 3 rounds, most recently a $90.0M Series C round in Jun 2024. Investors include Versant Ventures, RA Capital Management and Johnson & Johnson Innovation.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CJun 2024
$90.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bright Peak Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/bright-peak-therapeutics"><img src="https://indexed.vc/api/badge/company/bright-peak-therapeutics" alt="Bright Peak Therapeutics on Indexed.vc" width="260" height="76" /></a>